Examining effects of whole-body vibration on osteoporosis

Osteoporosis is a major healthcare problem leading to a high incidence of hip and spine fractures in the ageing population.

In Australia, one in two women over 60 will suffer an osteoporotic fracture, with hip fractures being the most costly economically.

Currently, medication is the only proven therapy for the prevention of osteoporotic fractures.

WHY IS THE RESEARCH BEING CONDUCTED?

Osteoporotic fractures at the hip and spine are major health concerns of aging with drugs being the only proven therapy for the prevention of osteoporotic fracture. In Australia, 1 in 2 women over 60 will suffer a osteoporotic fracture with hip fractures being the most costly economically and in terms of pain and suffering.

Whole body vibration (WBV) is a novel therapy that has been shown to improve bone mass in animal studies. Some human research has also reported promising findings but a large enough study has not yet been conducted to know for sure. Exercise is known to be beneficial for bone but its effect in combination with vibration is unknown. We have been funded by the government to run a trial to examine vibration, exercise and a combination of the two.

Are you eligible?

We are looking for women who are:

  • aged 60 or older
  • five years postmenopausal
  • not over 125 kg
  • have low bone mass (we can test you for this).

If you are 5 years post-menopause but younger than 60 years, please contact study investigators as you may still be eligible for the study.

Expected Benefits

We believe that WBV will reduce the risk of hip fracture with or without osteoporotic medications and thereby identify an important advance in osteoporosis therapy. If it does not, our research will have ruled out an ineffectual therapy. Either finding has the potential to translate to very large savings in future healthcare costs.

You will personally benefit from your participation by receiving a series of free bone, muscle and fat scans, including a full interpretation of results, to an approximate value of $1000. You will also be provided with free estimate of your daily calcium consumption and your vitamin D status.

Registrations

Recruitment for the VIBMOR trial will begin in March 2018. To be part of this trial please register your interest.

Required fields are marked with an asterisk (*).
Details
Women over the age of 60 are eligible to participate in this study
Privacy
Privacy Infomation * Your privacy is important to us. Information you supply will be handled strictly in accordance with our Privacy Plan.

Contact us

Research Assistant - Ms Meret Wandeler

(07) 5552 9659

Research Assistant - Ms Tiana Gibson

(07) 5552 9565

Email

This clinical trial has Griffith University' s Human Research Ethics Committee's (HREC) approval. (Ref: AHS/61/14/HREC)